Keyword: Dr. Robert Lewis

  • Drug Uniformity Remains Somewhat Elusive

    Though studies have been completed to determine threshold levels for almost 20 therapeutic medications, it doesn't mean the industry will know for certain whether the drugs can impact equine performance.

  • RMTC Board Recommends Steroid Policy

    The board of directors of the Racing Medication and Testing Consortium (RMTC), in consultation with the RMTC Scientific Advisory Committee, approved policy recommendations for the use of steroids. The action took place at an RMTC board meeting March 25 Austin, Texas.

  • RMTC: Regulate Steroids Uniformly

    Members of the Racing Medication and Testing Consortium haven't backed away from a call for regulation of anabolic steroids in racehorses, but on Jan. 31 they endorsed a Dec. 31, 2008, deadline for nationwide adoption of a model rule.

  • Drug Contaminants, 'Zero Tolerance' on Collision Course

    Research shows small amounts of stimulants and therapeutic drugs can be detected in stalls and other locations on the backstretch, and that has horsemen concerned given sensitive testing methods and regulations that don't make provisions for environmental contamination.